Phase 2 Eczema Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Be at least 2 years old
• Have a primary care doctor or provider located near where you live
• Be able to speak and understand English (this can apply to a parent or caregiver who will be filling out questionnaires on behalf of the participant)
• Have been diagnosed with atopic dermatitis (eczema) for at least 3 months before the screening visit, meeting specific diagnostic guidelines that include at least 3 "major" signs (such as itching, typical skin rash patterns, long-lasting or recurring skin inflammation, or a personal/family history of allergies, asthma, or hay fever) AND at least 3 "minor" signs (such as dry skin, skin infections, food intolerance, itching when sweating, or other related skin and eye features — confirm full list with trial site)
• Have eczema that is at least mildly active at the time of joining, based on standard scoring tools used by doctors (confirm details with trial site)
• If sexually active and able to become pregnant, agree to use an approved form of birth control from the screening visit until 30 days after finishing the study treatment
• Be willing and able to attend all required study visits and follow study procedures
• Be able to give consent to participate (or have a parent/legal guardian do so for children)
• Be willing to take part in virtual (online/remote) visits

Who may not be able to join:

• Has used certain medications to suppress or modify the immune system (such as steroids by mouth/injection, azathioprine, methotrexate, or cyclosporine) within the past 4 weeks
• Has received light therapy (phototherapy) for eczema within the past 4 weeks
• Has newly started certain eczema treatments within the past 12 weeks, including topical steroids, certain skin creams (calcineurin inhibitors or PDE4 inhibitors), JAK inhibitor pills or creams, dupilumab or similar injectable/biologic medicines, certain moisturisers containing specific ingredients (ceramides, hyaluronic acid, urea, or filaggrin products), or bleach baths
• Has a current infection (short-term or ongoing) that required antibiotic, antiviral, or antifungal medication taken by mouth or injection within the past 2 weeks
• Has a current skin infection requiring a prescription cream or ointment within the past week
• Has a known or suspected condition that weakens the immune system
• Has a permanent tube or line inserted into a large vein (known as an indwelling central line)
• Lives with someone who has a weakened immune system or has a central line
• Has any significant health concerns that the study doctor feels could put the participant at increased risk (confirm with trial site)
• Is currently pregnant or breastfeeding
• Is a female who has periods but has not had a period in the last 6 weeks before screening (unless using an intrauterine device or long-term implanted contraceptive that naturally stops periods)

Important: Always verify eligibility with the trial site directly before applying.